Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Standardized Microbiota Transplant Therapy in Crohn's Disease
for
Crohn Disease
Location: Dallas TX, Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18 - 70+
Code: NCT06631586
Phase 2, Recruiting
Study of SGR-3515 In Participants With Advanced Solid Tumors.
for
Advanced Solid Tumor
Location: Dallas TX, Oklahoma City OK, Nashville TN, Chicago IL,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT06463340
Phase 1, Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Dallas TX, Houston TX, St Louis MO, Iowa City IA,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
for
Ulcerative Colitis, Crohn Disease
Location: Dallas TX, Houston TX, Aurora CO, Chicago IL,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05230173
Recruiting
Converting HR+ Breast Cancer Into an Individualized Vaccine
for
Breast Cancer
Location: Dallas TX, Houston TX, New York NY
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 70+
Code: NCT03804944
Phase 2, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase 1, Recruiting
A Polypill for Acute Coronary Syndrome
for
Acute Coronary Syndrome
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center